LGVN
Longeveron LLC
NASDAQ: LGVN · HEALTHCARE · BIOTECHNOLOGY
$0.85
-1.74% today
Updated 2026-04-30
Market cap
$26.35M
P/E ratio
—
P/S ratio
21.98x
EPS (TTM)
$-1.29
Dividend yield
—
52W range
$0 – $2
Volume
6.9M
Longeveron LLC (LGVN) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-5.18M | $-2.39M | $-2.36M | $-9.64M | $-13.97M | $-19.00M | $-13.87M | $-18.64M |
| Capital expenditures | $211684.00 | $37573.00 | $261500.00 | $1.31M | $856000.00 | $301000.00 | $992000.00 | $245000.00 |
| Depreciation | — | — | — | — | — | — | — | — |
| Stock-based comp | $423866.00 | $136846.00 | $83000.00 | $7.74M | $2.17M | $2.03M | $2.33M | $1.68M |
| Free cash flow | $-5.39M | $-2.43M | $-2.63M | $-10.95M | $-14.82M | $-19.30M | $-14.86M | $-18.89M |
| Investing cash flow | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | $451000.00 | — | — | $8.65M | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $24.84M | $-15.15M | — | — | — |